Public Health England
Insufficient evidence for vitamin D preventing or treating ARTIs
NICE and SACN have reviewed available evidence on vitamin D and the risk of acute respiratory tract infections (ARTIs) and COVID-19.
- there is insufficient evidence on the role of vitamin D and risk of respiratory tract infections
- PHE, SACN and NICE will continue to monitor and assess emerging evidence in this field
- current UK government advice to take a daily 10 microgram vitamin D supplement to protect musculoskeletal health still applies
Vitamin D is needed to keep bones and muscles healthy. It has also been suggested that vitamin D could reduce the risk of Acute Respiratory Tract Infections (ARTIs) and COVID-19.
This has been explored in 2 new rapid reviews, published yesterday, from the Scientific Advisory Commission on Nutrition (SACN) and the National Institute for Health and Care Excellence (NICE). PHE commissioned SACN to examine new evidence on whether vitamin D supplementation could reduce the risk of ARTIs and supported NICE to review emerging evidence on vitamin D and the prevention and treatment of COVID-19.
SACN rapid review
SACN’s rapid review assessed evidence on vitamin D and ARTIs that had been published since the last SACN review in 2016. ARTIs refers to any infection of the sinuses, throat, airways or lungs. The review did not look specifically at the effect of vitamin D supplementation on COVID-19 risk.
The review concluded that evidence currently does not support vitamin D supplementation to prevent ARTIs in the general UK population. The review reiterates the importance of vitamin D for bone and muscle health.
Sunlight is the primary source of Vitamin D. That is why with ‘stay at home’ measures in place the UK government re-issued advice at the beginning of April 2020 that everyone takes a daily vitamin D supplement to mitigate the effects of reduced time outdoors.
Dr Alison Tedstone, Chief Nutritionist, PHE, yesterday said:
With many people spending more time indoors, particularly the more vulnerable groups and those ‘shielding’, there is a risk that some people may not be getting all the vitamin D they need from sunlight. It’s important they consider taking a daily 10 micrograms vitamin D supplement to help protect bone and muscle health.
NICE evidence summary
PHE also supported the National Institute for Health and Care Excellence (NICE) to conduct a rapid evidence summary evaluating emerging evidence on vitamin D in relation to COVID-19.
The review included 5 observational studies on vitamin D and COVID-19 published on or before 18 June 2020. All 5 studies were assessed as being very low quality evidence, at high risk of bias. There was no data from clinical trials on vitamin D supplementation for the prevention or treatment of COVID-19 available.
The review concluded that there is currently no evidence to support taking vitamin D supplements to reduce the risk or severity of COVID-19.
Paul Chrisp, Director for the Centre for Guidelines, NICE, yesterday said:
While there are health benefits associated with vitamin D, our rapid evidence summary did not identify sufficient evidence to support the use of vitamin D supplements for the treatment or prevention of COVID-19.
We know that the research on this subject is ongoing, and NICE is continuing to monitor new published evidence.
NICE rapid evidence summaries differ from NICE guidance in that they do not include recommendations but offer an assessment of the best available evidence for a selected topic, which may then be used alongside other available information (such as the specific patient circumstances), to inform individual health care decisions.
Impact on BAME groups
Existing advice highlights that people who have dark skin, for example with an African, African-Caribbean or south Asian background, may not get enough vitamin D from sunlight and it is recommended that they consider taking a daily supplement containing 10 micrograms of vitamin D throughout the year.
The SACN 2016 review found a lack of available evidence on the role of vitamin D in Black, Asian and Minority Ethnic groups, with the report recommending that further research is undertaken on “whether there are differences in dietary vitamin D requirements of ethnic groups in the UK”.
PHE, SACN and NICE are aware that a systematic review and controlled trials on vitamin D and COVID-19 are underway and will continue to monitor and assess new evidence as it is published.
Latest News from
Public Health England
Landmark report reveals harms associated with gambling estimated to cost society at least £1.27 billion a year01/10/2021 10:10:10
PHE yesterday published the first comprehensive review of the evidence on gambling harms and their impact in England, using the best available scientific evidence.
Smokers encouraged to take part in Stoptober, as they report smoking more during pandemic21/09/2021 11:10:00
Stoptober is back and calling on smokers to join the 2.3 million people who have made quit attempts since the campaign’s launch 10 years ago.
JCVI issues updated advice on COVID-19 booster vaccination14/09/2021 15:25:00
The Joint Committee on Vaccination and Immunisation (JCVI) has updated its advice on the COVID-19 vaccine booster programme.
Campaign launched to help public get healthy this summer08/09/2021 14:20:00
PHE has launched the latest Better Health campaign to encourage adults across the nation to lose excess weight, eat more healthily and get active this summer.
STI rates remain a concern despite fall in 202007/09/2021 11:15:00
New data from Public Health England (PHE) reveal that diagnoses of sexually transmitted infections (STIs) decreased in 2020 by 32% compared to 2019.
JCVI issues updated advice on COVID-19 vaccination of children aged 12 to 1506/09/2021 09:25:00
The JCVI has reviewed the evidence on vaccinating children aged 12 to 15 who do not have underlying health conditions that put them at increased risk from severe COVID-19.
JCVI issues advice on third dose vaccination for severely immunosuppressed02/09/2021 13:10:00
The JCVI is advising that people with severely weakened immune systems should have a third vaccine dose as part of their primary COVID-19 vaccination schedule.
UKHSA launches study to better understand COVID-19 vaccine response27/08/2021 10:10:10
UKHSA has been awarded funding to lead a consortium of research partners to better understand how individuals respond to the coronavirus (COVID-19) vaccines.